News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Roche Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/19/2014
Actavis Ordered To Keep Selling Alzheimer's Pill     12/12/2014
Investors Cheer As Biogen Idec's BIIB037 Skips To Phase 3 For Alzheimer's     12/4/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec Needs?     12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
AstraZeneca PLC And Eli Lilly Move Alzheimer's Drug Into Big Trial     12/1/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Astellas Pharma Inc., CoMentis, Inc. Terminate Alzheimer's Agreement     10/17/2014
Actavis Will Keep Selling Alzheimer's Drug In U.S. For 60 Days     9/26/2014
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's     9/16/2014
AVANIR Pharmaceuticals Rockets As Lead Drug Succeeds In Reducing Alzheimer's Related Agitation; Stock Up 63.20% At 10:19AM ET On Monday     9/16/2014
Roche Alzheimer's Drug Crenezumab Fails Main Goals In Phase 2 Study     7/17/2014
Targacept, Inc. Stops Alzheimer's Drug Trial After It Fails Phase 2b Trial     7/16/2014
Novartis AG To Test Alzheimer's Drugs In Patients Without Symptoms     7/15/2014
German Database Study Hints Takeda Pharmaceutical Co. Ltd.'s Diabetes Drug Cuts Alzheimer's Risk     7/14/2014

Featured Stories
Now Researchers Can See How Unfolded Proteins Move In The Cell, University of Illinois Reveals     12/11/2014
Imaging Shows Brain Connection Breakdown In Early Alzheimer's Disease, Duke University Medical Center Study     12/2/2014
Regular Coffee Consumption Could Keep Alzheimer's At Bay, Institute For Scientific Information On Coffee Study     12/1/2014
Brain Network May Be Vulnerable To Alzheimer’s And Schizophrenia, Oxford University Study     11/26/2014
Stanford University Biologists Explore Link Between Memory Deficit And Misfiring Circadian Clock     11/24/2014
Complex Jobs "May Protect Memory," Heriot-Watt University Study     11/20/2014
Does "Brain Training" Work? University of Sydney Study     11/20/2014
Dementia Study Questions Advice On Taking Supplements, Wageningen University Reveals     11/14/2014
Anxiety Can Damage Brain, Accelerate Alzheimer’s, Baycrest Health Sciences Study     11/11/2014
High-Fat Diet May Postpone Aging, University of Copenhagen Study     11/7/2014
Cocoa May Reverse Age-Related Memory Decline, Columbia University Medical Center Study     10/28/2014
Walnuts May Help Protect Against Alzheimer’s Disease, New York State Institute For Basic Research In Developmental Disabilities Reveals     10/23/2014
Scientists Inch Closer To Alzheimer's Origins, Massachusetts General Hospital Study     10/16/2014
Memory Loss From Alzheimer's Reversed, University of California, Los Angeles (UCLA) Study     10/9/2014
Jealousy, Moody Women, And Alzheimer's Risk, University of Gothenburg Study     10/6/2014

More News
Roche (RHHBY) Provides Update On Gantenerumab Development Programme     12/19/2014
Alzheimer's Drug Discovery Foundation Release: US Nonprofit Awards Italian Biotech Additional Funding To Study New Class Of Drugs To Treat Alzheimer's Disease     12/19/2014
Anavex Life Sciences Corp. (AVXL.OB) Begins Enrollment Of Alzheimer's Patients In Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS     12/16/2014
The ALS Association And Muscular Dystrophy Association Team Up To Advance ALS Therapy Concept     12/4/2014
Radiological Society of North America (RSNA) Release: Imaging Shows Brain Connection Breakdown In Early Alzheimer's Disease     12/1/2014
Neurotrope Announces Last Patient Dosed In Phase 2a Clinical Trial Of Bryostatin-1 For Alzheimer's Disease     11/20/2014
Neurotrope Announces Last Patient Dosed In Phase 2a Clinical Trial Of Bryostatin-1 For Alzheimer’s Disease     11/20/2014
Anavex Life Sciences Corp. (AVXL.OB) Announces Positive Phase 1 Data For ANAVEX 2-73, Lead Candidate For The Treatment Of Alzheimer's     11/17/2014
Virobay Inc. To Present Data On Two Cathepsin S Inhibitor Programs In Neuropathic Pain And Alzheimer's Disease At The 2014 Society for Neuroscience Annual Meeting     11/14/2014
Cognition Therapeutics Inc.Announces Publication Of Research Identifying Sigma-2/PGRMC1 Receptor As A Major New Drug Target For Alzheimer's Disease Therapy     11/13/2014
GliaCure's Lead Product, GC021109, Receives FDA Fast Track Designation     11/12/2014
Cortice Biosciences Announces Results From Studies Evaluating Pipeline Candidates TPI 287 And CRT 001 In Preclinical Models Of Tauopathies And Alzheimer's Disease     11/12/2014
Anavex Life Sciences Corp. (AVXL.OB) Receives Regulatory Approval To Initiate Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS For Alzheimer's Disease     11/3/2014
Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease     10/28/2014
Vitae Pharmaceuticals, Inc. (VTAE) Release: Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials Of BACE Inhibitor BI1181181/VTP-37948 In Alzheimer's Disease     10/24/2014